Literature DB >> 26810033

Transdermal immunization of P. falciparum surface antigen (MSP-119) via elastic liposomes confers robust immunogenicity.

Rajeev K Tyagi1,2, Neeraj K Garg3, Sarat K Dalai2, Amit Awasthi4.   

Abstract

As transdermal immunization results in poor immunogenicity, which is attributed to poor permeability of antigens through the skin, we believed ultradeformable lipid vesicles (elastic liposome) might address the challenges encountered during transdermal immunization. The elastic liposome, versatile carrier, proves better vehicle for transcutaneous delivery of protein, peptide and nucleic acid antigens. Our recently published article (1) is suggestive of improved immunogenicity of carboxyl-terminal 19 kDa fragment of merozoite surface protein-1 (PfMSP-119) of Plasmodium falciparum when administered subcutaneously via elastic liposomes ( Fig. 1 ).

Entities:  

Keywords:  Cellular and humoral immunity; Elastic liposome; Immunization; Langerhans cells; MSP-119; Transdermal delivery; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 26810033      PMCID: PMC4962934          DOI: 10.1080/21645515.2015.1116656

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  22 in total

Review 1.  Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.

Authors:  S A Hammond; M Guebre-Xabier; J Yu; G M Glenn
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2001       Impact factor: 4.889

2.  Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.

Authors:  C Hirunpetcharat; J H Tian; D C Kaslow; N van Rooijen; S Kumar; J A Berzofsky; L H Miller; M F Good
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

3.  Skin immunization made possible by cholera toxin.

Authors:  G M Glenn; M Rao; G R Matyas; C R Alving
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

Review 4.  Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells.

Authors:  A F Cowman; D L Baldi; J Healer; K E Mills; R A O'Donnell; M B Reed; T Triglia; M E Wickham; B S Crabb
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

5.  Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119.

Authors:  Rajeev K Tyagi; Neeraj K Garg; Rajesh Jadon; Tejram Sahu; Om Prakash Katare; Sarat K Dalai; Amit Awasthi; Srujan K Marepally
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

6.  Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.

Authors:  J H Tian; S Kumar; D C Kaslow; L H Miller
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force.

Authors:  G Cevc; G Blume
Journal:  Biochim Biophys Acta       Date:  1992-02-17

Review 8.  Protective antigens of rodent and human bloodstage malaria.

Authors:  A A Holder; R R Freeman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-11-13       Impact factor: 6.237

9.  Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.

Authors:  T M Daly; C A Long
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

10.  Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).

Authors:  N Ahlborg; I T Ling; A A Holder; E M Riley
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

View more
  3 in total

Review 1.  Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.

Authors:  Veena Vijayan; Adityanarayan Mohapatra; Saji Uthaman; In-Kyu Park
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

Review 2.  Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis.

Authors:  Amarjitsing Rajput; Satish Mandlik; Varsha Pokharkar
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

Review 3.  The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination.

Authors:  Rayen Yanara Valdivia-Olivares; Maria Rodriguez-Fernandez; María Javiera Álvarez-Figueroa; Alexis M Kalergis; José Vicente González-Aramundiz
Journal:  Vaccines (Basel)       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.